U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463508) titled 'Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity' on Dec. 26, 2025.
Brief Summary: This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Testicular Germ Cell Cancer
Intervention:
BIOLOGICAL: blood sampling
Blood samples will allow the measurement of AFP, LDH and HCG as well as the measure...